A Prospective Evaluation of Infraorbital Filler Injection

A Prospective Evaluation of Infraorbital Filler Injection

The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photography at 2 weeks, 1 month, and 3 months post-injection.

Undereye or infraorbital hollowing is a result of a loss of volume causing shadowing and darkness of the infraorbital region often interpreted as a tired, stressed, and aged appearance.

The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photography and to complete a validated patient satisfaction questionnaire at 2 weeks, 1 month, and 3 months post-injection. 3D photogrammetry technology allows for high level feature enhancement and microscopic anatomical evaluation that was not previously possible and can be used to make volumetric measurements at injection sites to evaluating minimally invasive injection efficacy.

Inclusion Criteria:

• female
• age 22 to 65
• interested in filler injections to reduce undereye volume loss

Exclusion Criteria:

• male
• age <22 or >65
• prior undereye filler
• filler/neurotoxin injection within the past 12 months
• prior facial cosmetic surgery
• prior facial trauma
• planned dental work within next 2 weeks
• travel 1 week prior or 2 weeks after injection